A Training and Calibration Study in the Use of the DIAGNOdent
Investigation of an Investigational Treatment for Migraine Prevention
Not Recruiting
18 years - 65 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Healthy
Age:
18 years - 65 years
Gender: All
Who can participate: Adults aged 18 to 65 who experience frequent migraines, defined as having at least four migraine days per month, are eligible to participate. Key exclusions include those with other significant neurological disorders or those currently using other migraine prevention treatments.
Study details: Participants will undergo an initial screening followed by a baseline period where migraine frequency is recorded. They will then be randomly assigned to receive either the investigational medication or a placebo for a period of 12 weeks. A placebo is an inactive substance designed to mimic the investigational medication. Participants will maintain a headache diary throughout the study.
Updated on
19 Feb 2024.
Study ID: 0410-76
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
